UAB Study Leads to New FDA Approved Drug for Sickle Cell Anemia

Written by Dakota Layton on January 6, 2020

— wp:paragraph –>

“There are many issues with sickle cell disease, and access to care is a big one.

Dakota Layton graduated from the University of Alabama in Huntsville with a Bachelor of Arts in Philosophy. He is currently enrolled at the University of Mississippi where he is working to earn his Master of Arts in Philosophy.

Topic tags:

UAB Study Leads to New FDA Approved Drug for Sickle Cell Anemia

Dakota Layton

Read Next

The Apocalyptic Permission Structure: How Holy War is Bleeding America Dry

Alabama Wants Fewer Voters. The SAVE Act Is How.

The Death of Expertise in Alabama

Meet Brandaun Dean, Alabama Democratic U.S. Senate Candidate